The diarylquinoline TMC207 for multidrug-resistant tuberculosis.
暂无分享,去创建一个
Gavin Churchyard | Alexander Pym | Paul Meyvisch | Koen Andries | Martin Grobusch | A. Diacon | J. Palomino | K. Andries | G. Churchyard | Jenny Allen | R. Rustomjee | M. Grobusch | N. Lounis | A. Pym | A. Venter | P. Meyvisch | Andreas H Diacon | Wim Parys | K. de Beule | Ramonde Patientia | Roxana Rustomjee | Liesl Page-Shipp | Christoffel Pistorius | Rene Krause | Mampedi Bogoshi | Amour Venter | Jenny Allen | Juan Carlos Palomino | Tine De Marez | Rolf P G van Heeswijk | Nacer Lounis | Johan Verbeeck | Karel de Beule | David F Mc Neeley | R. V. van Heeswijk | D. F. Mc Neeley | J. Verbeeck | L. Page-Shipp | W. Parys | R. Patientia | T. De Marez | R. Krause | M. Bogoshi | Christoffel Pistorius | J. Allen
[1] K. Castro,et al. Randomized Trials to Optimize Treatment of Multidrug-Resistant Tuberculosis , 2007, PLoS medicine.
[2] M. Perkins,et al. Confronting the scientific obstacles to global control of tuberculosis. , 2008, The Journal of clinical investigation.
[3] Christopher Dye,et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. , 2003, Archives of internal medicine.
[4] Charles L Daley,et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. , 2003, American journal of respiratory and critical care medicine.
[5] A. Matteelli,et al. Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control , 2007, Expert review of anti-infective therapy.
[6] K. Andries,et al. Prevention of Drug Carryover Effects in Studies Assessing Antimycobacterial Efficacy of TMC207 , 2008, Journal of Clinical Microbiology.
[7] L. Tanoue. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis , 2008 .
[8] F. Portaels,et al. Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. , 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[9] P. Verhasselt,et al. In Vitro Antimycobacterial Spectrum of a Diarylquinoline ATP Synthase Inhibitor , 2007, Antimicrobial Agents and Chemotherapy.
[10] L. Sacks,et al. Developing new drugs for the treatment of drug-resistant tuberculosis: a regulatory perspective. , 2008, Tuberculosis.
[11] Hinrich W. H. Göhlmann,et al. A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis , 2005, Science.
[12] S. Bihari,et al. A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[13] K. Andries,et al. Combinations of R207910 with Drugs Used To Treat Multidrug-Resistant Tuberculosis Have the Potential To Shorten Treatment Duration , 2006, Antimicrobial Agents and Chemotherapy.
[14] Dirk Bald,et al. Diarylquinolines target subunit c of mycobacterial ATP synthase. , 2007, Nature chemical biology.
[15] Captain Y. B. Nusfield. Public Health , 1906, Canadian Medical Association journal.
[16] K. Andries,et al. Synergistic Activity of R207910 Combined with Pyrazinamide against Murine Tuberculosis , 2006, Antimicrobial Agents and Chemotherapy.
[17] Hinrich W. H. Göhlmann,et al. Diarylquinolines Are Bactericidal for Dormant Mycobacteria as a Result of Disturbed ATP Homeostasis* , 2008, Journal of Biological Chemistry.
[18] S. Gillespie,et al. Biomarkers of treatment response in clinical trials of novel antituberculosis agents. , 2007, The Lancet. Infectious diseases.
[19] G. Bai,et al. Worldwide Emergence of Extensively Drug-resistant Tuberculosis , 2007, Emerging infectious diseases.
[20] A. Diacon,et al. Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis , 2008, Antimicrobial Agents and Chemotherapy.
[21] A. Diacon,et al. The early bactericidal activity of anti-tuberculosis drugs: a literature review. , 2008, Tuberculosis.
[22] Mehran Hosseini,et al. Global incidence of multidrug-resistant tuberculosis. , 2006, The Journal of infectious diseases.